CONTENTS:
- Alcohol-free spirits as novel alcohol placebo - A viable approach to reduce alcohol-related harms? [Editorial] Lachenmeier D.W., Pflaum T., Nieborowsky A., Mayer S., Rehm J., p. 1-2.
- A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011. Marotta P.L., McCullagh C.A., p. 3-10.
- Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research. Friedman S.R., Tempalski B., Brady J.E., West B.S., Pouget E.R., Williams L.D., et al., p. 11-16.
- Withholding differential risk information on legal consumer nicotine/tobacco products: The public health ethics of health information quarantines. Kozlowski L.T., Sweanor D., p. 17-23.
- What is known about community pharmacy supply of naloxone? A scoping review. Nielsen S., Van Hout M.C., p. 24-33.
- Scepticism and hope in a complex predicament: People with addictions deliberate about neuroscience. Meurk C., Morphett K., Carter A., Weier M., Lucke J., Hall W., p. 34-43.
- The effects of extended public transport operating hours and venue lockout policies on drinking-related harms in Melbourne, Australia: Results from SimDrink, an agent-based simulation model. Scott N., Hart A., Wilson J., Livingston M., Moore D., Dietze P., p. 44-49.
- Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Des Jarlais D.C., Thi Huong D., Thi Hai Oanh K., Khuê Pham M., Thi Giang H., Thi Tuyet Thanh N., et al., p. 50-56.
- HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys. Handanagic S., Bozicevic I., Civljak M., Dominkovic Z., Sevic S., Barbaric J., et al., p. 57-63.
- Low HIV testing rate and its correlates among men who inject drugs in Iran. Shokoohi M., Karamouzian M., Osooli M., Sharifi H., Fahimfar N., Haghdoost A., et al., p. 64-69.
- Benefits of short educational programmes in preventing drink-driving recidivism: A ten-year follow-up randomised controlled trial. Vaucher P., Michiels W., Joris Lambert S., Favre N., Perez B., Baertschi A., et al., p. 70-76.
- The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations. Soussan C., Kjellgren A., p. 77-84.
- Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling. Manning M., Wong G.T.W., Ransley J., Smith C., p. 85-92.
- Depoliticising the political: Market solutions and the retreat of Swedish institutional drug treatment from state management. Edman J., p. 93-99.
- Blacks face higher risk of drug arrests in White neighborhoods. Fielding-Miller R., Davidson P., Raj A., p. 100-103.
- Collaborative transition to a methadone formulation change in British Columbia, Canada. Greer A., Amlani A., Buxton J., p. 104-105.